Wellstar International, Inc. Through Its Wholly Owned Subsidiary Trillennium Medical Imaging (TMI) Announces the Development of the TMI Clinical Camera Design and Production

HOLLAND, Ohio--(BUSINESS WIRE)--(OTCBB:WLSI) -- With the results of the clinical trial at Duke University Medical Center completed, and the pending publication of the results, TMI is pleased to announce the development of their new clinical imaging system. The technology that was used in the clinical trial to detect patterns of injury associated with the development of pressure ulcers before being clinically visible remains the same, but the addition of certain features and benefits will allow the imaging system to be a viable solution for any healthcare facility concerned with patient safety and decreasing pressure ulcer occurrence.

MORE ON THIS TOPIC